Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

BSE confirmed in France
Cows
BSE was first detected in Britain in the late 1980s.
Discovered in the northeastern region of Ardennes

A case of bovine spongiform encephalopathy (BSE) has been confirmed in France following tests on a five-year-old cow.

Discovered in the northeastern region of Ardennes, the isolated case was confirmed on March 23, 2016 by the reference laboratory of the European Union.

It is the third single case of BSE of this type detected in Europe since 2015 and is likely to have an impact on beef exports.

In a statement on their website, the French Ministry said: “The detection of this case does not affect the consumer. Beef consumption is safe for humans.”

However that add that the outbreak is likely to affect French exports because the country’s official BSE risk level assigned by the Office of International Exports (OIE) would be changed.

“Depending on countries, export conditions of French cattle could be modified,” it said.

In 2015, France regained the safest BSE rating of “negligible risk” as it was able to show that the last infected animals was born over 11 years ago.

Several countries, including South Africa, Vietnam and Singapore lifted embargoes on French beef following the OIE decision.

BSE was first detected in Britain in the late 1980s, spreading to other parts of Europe and destroying cattle herds until the early 2000s.

The disease has been linked to Creutzfeldt-Jakob disease (CJD) in humans - a rare, degenerative and invariably fatal neurological condition. 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.